BioCrine AB Company
Biocrine’s goal is to commercialize new concepts of treatment and enable continual delivery of novel drugs both for diabetes itself and for the complications that this disease induces.
Industry:
PharmTech
Headquarters:
Solna, Stockholms Lan, Sweden
Zip:
1-10
Founded Date:
2008-01-01
Employees Number:
1-10
Total Funding:
Less than $1M
Estimated Revenue:
Less than $1M
Register and Claim Ownership